- Fotemustine USP/EP/BP
-
- $1.10 / 1g
-
2021-07-06
- CAS:92118-27-9
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
- Fotemustine
-
- $1.00 / 1KG
-
2020-02-19
- CAS:92118-27-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 200kgs
|
| Fotemustine Basic information |
Product Name: | Fotemustine | Synonyms: | 1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea;FOTEMUSTINE;Fotemustin;Muphoran;S-10036;Phosphonic acid, P-[1-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]ethyl]-, diethyl ester;[1-[[[(2-Chloroethyl)nitlx~amino]carbonyl]amino]ethyl]phosphonic acid diethyl ester;[1-[[[(2-Chloroethyl)nitrosoamino]carbonyl]amino]ethyl]phosphonic acid diethyl ester | CAS: | 92118-27-9 | MF: | C9H19ClN3O5P | MW: | 315.69 | EINECS: | | Product Categories: | | Mol File: | 92118-27-9.mol |  |
| Fotemustine Chemical Properties |
Melting point | 85° | density | 1.37±0.1 g/cm3(Predicted) | storage temp. | 2-8°C | solubility | H2O: ≥1mg/mL | form | powder | pka | 9.47±0.46(Predicted) | color | light yellow | CAS DataBase Reference | 92118-27-9(CAS DataBase Reference) |
| Fotemustine Usage And Synthesis |
Description | Fotemustine is a new nitrosourea reportedly effective in the treatment of disseminated
malignant melanoma, with only mild hematological toxicity. Response rate is generally
lower in patients with colonic, breast, head and neck cancer. | Originator | Servier (France) | Uses | Fotemustine is used in patients malignant gliomas to improve the efficacy of radiotherapy. Used in the treatment of glioblastomas. | Definition | ChEBI: Diethyl (1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl)phosphonate is a member of the class of N-nitrosoureas that is ethyl diethylphosphonate in the hydrogen at position 1 of the ethyl group attached to the phosphorus has been replaced by a [(2-chloroethyl)(nitroso)carbamoyl]amino group. It is an organic phosphonate, a member of N-nitrosoureas and an organochlorine compound. | Brand name | Muphoran |
| Fotemustine Preparation Products And Raw materials |
|